Sequana Medical NV
EBR:SEQUA.BR
0.902 (EUR) • At close September 16, 2024
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) EUR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Omzet
| 0.712 | 0.923 | 0.371 | 0.963 | 0.971 | 1.029 | 1.304 | 1.489 | 1.685 |
| Kosten van de omzet
| 4.866 | 0.205 | 0.077 | 0.202 | 0.198 | 0.158 | 0.212 | 0.32 | 0.359 |
| Brutowinst
| -4.154 | 0.718 | 0.294 | 0.761 | 0.773 | 0.871 | 1.092 | 1.168 | 1.326 |
| Brutowinstmarge
| -5.833 | 0.778 | 0.793 | 0.79 | 0.796 | 0.846 | 0.837 | 0.785 | 0.787 |
| Onderzoek- en ontwikkelingskosten
| 5.277 | 7.707 | 6.14 | 4.437 | 2.521 | 0.935 | 1.174 | 1.146 | 0.995 |
| Algemene en administratieve kosten
| 6.943 | 6.687 | 5.098 | 4.417 | 4.264 | 5.761 | 1.988 | 4.059 | 3.286 |
| Verkoop- en marketingkosten
| 1.799 | 2.24 | 2.079 | 2.322 | 2.838 | 2.445 | 1.506 | 3.337 | 2.988 |
| Verkoop-, algemene en administratieve kosten
| 20.322 | 8.927 | 7.177 | 6.738 | 7.102 | 8.206 | 3.494 | 7.396 | 6.274 |
| Overige kosten
| -5.277 | 19.885 | 15.73 | 11.794 | 7.634 | 0.074 | 0.004 | 0.021 | 0.264 |
| Bedrijfskosten
| 25.599 | 28.813 | 22.907 | 18.532 | 14.736 | 13.948 | 8.51 | 15.113 | 12.681 |
| Bedrijfsresultaat
| -29.753 | -28.387 | -22.649 | -17.874 | -14.071 | -13.038 | -7.571 | -13.744 | -11.424 |
| Bedrijfsresultaat ratio
| -41.778 | -30.765 | -61.132 | -18.555 | -14.497 | -12.668 | -5.806 | -9.232 | -6.78 |
| Totaal overige inkomsten en kosten netto
| -2.972 | -1.99 | -0.573 | -1.076 | -0.771 | -0.922 | -0.636 | -0.19 | -0.089 |
| Inkomen voor belasting
| -32.725 | -30.376 | -23.222 | -18.949 | -14.841 | -13.96 | -8.207 | -13.934 | -11.512 |
| Inkomen voor belasting ratio
| -45.951 | -32.922 | -62.677 | -19.672 | -15.29 | -13.564 | -6.294 | -9.359 | -6.832 |
| Belastingkosten
| -0.162 | 0.387 | 0.393 | 0.157 | 0.136 | 0.024 | 0.018 | 0.041 | 0.044 |
| Nettowinst
| -32.564 | -30.763 | -23.615 | -19.106 | -14.977 | -13.983 | -8.225 | -13.975 | -11.557 |
| Nettowinstmarge
| -45.724 | -33.341 | -63.738 | -19.835 | -15.431 | -13.587 | -6.308 | -9.387 | -6.859 |
| WPA (Winst Per Aandeel)
| -1.22 | -1.35 | -1.3 | -1.25 | -1.22 | -1.02 | -0.6 | -1.02 | -0.85 |
| Verwaterde WPA
| -1.22 | -1.35 | -1.3 | -1.25 | -1.22 | -1.02 | -0.6 | -1.02 | -0.85 |
| EBITDA
| -29.092 | -28.075 | -22.241 | -17.567 | -13.827 | -12.957 | -7.493 | -13.664 | -11.377 |
| EBITDA ratio
| -40.85 | -30.428 | -60.029 | -18.237 | -14.245 | -12.59 | -5.747 | -9.178 | -6.752 |